Development asset linked to PLIANT THERAPEUTICS in public FDA and regional records.
pharma · Idiopathic Pulmonary Fibrosis · Idiopathic pulmonary fibrosis (IPF) · PLRX
PLIANT THERAPEUTICS
PLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
South San Francisco, USA HQ
2015 Founded
122 Employees
Public company Type
PLRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2015
- Employees
- 122
- Programs
- 6
- Drugs
- 3
- Patents
- 13
PLIANT THERAPEUTICS pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
PLIANT THERAPEUTICS drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to PLIANT THERAPEUTICS in public FDA and regional records.
-
Development asset linked to PLIANT THERAPEUTICS in public FDA and regional records.